Biomerica Inc
BMRA- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000073290
In the last 90 days, Biomerica Inc insiders filed 5 open-market purchases and 0 sales; 20 institutions reported holding it in 13F filings for Q2 2026, worth $220.0K in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Biomerica Inc as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −5 vs. Q2 2021
- Shares held
- 2.44M
- −117.0K (−4.6%) vs. Q2 2021
- Total value
- $11.0M
- +$806.0K (+7.9%) vs. Q2 2021
- New holders
- 3
- 5 more added
- Sold out
- 8
- 3 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BMRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $220.0K |
| Q1 2026 | 11 | $236.1K |
| Q4 2025 | 13 | $225.4K |
| Q3 2025 | 17 | $251.3K |
| Q2 2025 | 12 | $219.6K |
| Q1 2025 | 24 | $542.9K |
| Q4 2024 | 21 | $420.8K |
| Q3 2024 | 25 | $532.7K |
| Q2 2024 | 35 | $982.4K |
| Q1 2024 | 36 | $3.10M |
| Q4 2023 | 33 | $4.68M |
| Q3 2023 | 35 | $3.43M |
| Q2 2023 | 36 | $6.00M |
| Q1 2023 | 34 | $8.83M |
| Q4 2022 | 30 | $11.6M |
| Q3 2022 | 31 | $11.6M |
| Q2 2022 | 26 | $7.01M |
| Q1 2022 | 28 | $11.3M |
| Q4 2021 | 24 | $9.29M |
| Q3 2021 | 22 | $11.0M |
| Q2 2021 | 27 | $10.2M |
| Q1 2021 | 32 | $20.4M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Biomerica Inc; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Granahan Investment Management Inc | 1,031,358 | $4.64M | 0.09% | +3,049+0.3% | Added |
| Vanguard Group Inc | 581,110 | $2.62M | 0.00% | 00.0% | Unchanged |
| M&G Investment Management Ltd | 163,205 | $816.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 171,813 | $774.0K | 0.00% | +14,093+8.9% | Added |
| Fore Capital, LLC | 135,000 | $608.0K | 0.93% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 74,070 | $333.0K | 0.00% | 00.0% | Unchanged |
| Heritage Investors Management Corp | 69,350 | $312.0K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 54,631 | $246.0K | 0.00% | +400+0.7% | Added |
| GWM Advisors LLC | 31,400 | $141.0K | 0.00% | −2,800−8.2% | Reduced |
| Perritt Capital Management Inc | 30,000 | $135.0K | 0.07% | 00.0% | Unchanged |
| Emerald Advisers, LLC | 19,000 | $86.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 18,391 | $83.0K | 0.00% | 00.0% | Unchanged |
| Orion Capital Management LLC | 11,500 | $52.0K | 0.03% | 00.0% | Unchanged |
| Eudaimonia Partners, LLC | 11,000 | $50.0K | 0.01% | +11,000 | New |
| HCR Wealth Advisors | 10,000 | $45.0K | 0.01% | +10,000 | New |
| Simplex Trading, LLC | 10,500 | $44.0K | 0.00% | +3,700+54.4% | Added |
| Wells Fargo & Company | 6,563 | $29.0K | 0.00% | −1,936−22.8% | Reduced |
| Bank of America Corp | 4,056 | $18.0K | 0.00% | +24+0.6% | Added |
| Morgan Stanley | 1,645 | $7.00K | 0.00% | −4,992−75.2% | Reduced |
| Cutler Group LP | 700 | $3.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 50 | $0 | 0.00% | 00.0% | Unchanged |
| Leelyn Smith, LLC | 100 | $0 | 0.00% | +100 | New |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −104,580−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −17,773−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −14,118−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −10,719−100.0% | Sold out |
| American Portfolios Advisors | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −924−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −484−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |